ROXRO PHARMA, Inc. develops drugs for pain treatment. Its products include ROX-888, an intranasal formulation for the treatment of dental and postoperative pain; and ROX-828, a non-opioid and non-triptan intranasal product for the treatment of migraine. ROXRO PHARMA, Inc. was founded in 1999 and is based in Menlo Park, California.


Total FundingEmployeesLast Funding DateStatus

Crunchbase Investment Rounds

DateAmountRoundValuationLead InvestorOther Investors
2001-07-20$4,500,000Series A
2007-06-12$42,700,000Series BSutter Hill Ventures, Prospect Venture PartnersThomas Weisel Partners
2005-10-19$21,600,000Series BSutter Hill Ventures, Prospect Venture Partners